Karuna Therapeutics Inc.
09/01/2021 | Press release | Distributed by Public on 09/01/2021 04:37
Karuna Therapeutics to Present at 2021 Virtual Wells Fargo Healthcare Conference
BOSTON--(BUSINESS WIRE)--Sep. 1, 2021-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management will participate in a fireside chat at the 2021 Virtual Wells Fargo Healthcare Conference on Thursday, September 9, 2021, at 8:40 a.m. ET.
A live webcast of the fireside chat will be available on the Investor Relations page of Karuna's website at investors.karunatx.com. A replay of the webcast will also be archived for up to 30 days on Karuna's website following the conference.
About Karuna
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples' lives. For more information, please visit www.karunatx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210901005036/en/
Investor Contact:
Alexis Smith
518-338-8990
[email protected]
Source: Karuna Therapeutics, Inc.